Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Wellmark Medical Policy Updates – December 2022
Click here to view the Blue Cross Blue Shield BCBS Wellmark Medical Policy Updates »
December 2022 BCBS Wellmark Medical Policy Updates:
- Ambulatory Cardiac Event Monitoring and Real-time Outpatient Cardiac Telemetry
- Ambulatory Esophageal pH Monitoring
- Amniotic Membrane and Amniotic Fluid Grafts
- Anesthesia Services for Gastrointestinal (GI) Endoscopy Procedures
- Artificial Intervertebral Disc
- Balloon Ostial Dilation (BOD)/Balloon Sinuplasty for the Treatment of Chronic and Recurrent Rhinosinusitis as a Stand-Alone Procedure or as an Adjunctive Procedure to Functional Endoscopic Sinus Surgery (FESS)
- Bio-Engineered Skin and Soft Tissue Substitutes
- Biomarker Testing for Barrett’s Esophagus and Other Esophageal Disorders
- Carvykti (Ciltacabtagene Autoleucel)
- Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsies)
- Cochlear Implant Replacement
- Cognitive Rehabilitation
- Confocal Laser Endomicrsocopy
- Corneal Cross-Linking
- Cryoablation Radiofrequency Ablation and Laser Ablation for the Treatment of Chronic-Rhinitis
- Diaphragmatic/Phrenic Nerve Stimulation and Diaphragm Pacing Systems
- Donor Lymphocyte Infusion (DLI) and Hematopoietic Progenitor Cell (HPC) Boost
- Drug Testing in Pain Management and Substance Use Disorder Treatment
- Dry Needling
- Electrical Stimulation for the Treatment of Muscle Rehabilitation, Pain and Miscellaneous Conditions
- Expanded Genetic Panels to Identify Targeted Cancer Therapy
- External Upper Limb Stimulation for the Treatment of Tremors
- Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
- Gastric Electrical Stimulation
- Gene Expression Profiling for the Management of Breast Cancer
- Gene Expression Profiling for Uveal Melanoma
- Genetic Testing for Acute Myeloid Leukemia (AML)
- Genetic Testing for Familial Cutaneous Malignant Melanoma
- Genetic Testing in Myeloproliferative Disease
- Heart-Lung Transplant
- Hereditary Cancer Syndrome Multigene Panels Using Messenger RNA (mRNA)
- High Cost Naloxone Injectables
- Humanitarian Use Devices
- Implantable Bone Conduction Hearing Devices
- Implantable Peripheral Nerve Stimulation for the Treatment of Chronic Pain
- KRAS/NRAS and BRAF Mutation Analysis
- Kymriah (Tisagenlecleucel)
- Laparoscopic, Percutaneous and Transcervical Techniques for Uterine Fibroid Myolysis
- Leadless Cardiac Pacemaker
- Low-level Laser and High-Power Laser Therapy
- Lung and Lobar Lung Transplant
- Miscellaneous Bariatric Procedures
- Miscellaneous Surgical Treatments of Back Pain
- Molecular Analysis for Targeted Therapy of Non-Small Cell Lung Cancer
- Molecular Markers in Fine Needle Aspirates of the Thyroid
- Molecular Testing in the Management of Pulmonary Nodules
- Nasal Implants for Nasal Vestibular Lateral Wall Stenosis or Collapse
- Non-Invasive Glucose Monitoring Devices
- Non-Powered Negative Pressure Wound Therapy
- Osteochondral Allografts and Autografts
- Pancreas Transplants (Including Simultaneous Pancreas-Kidney, Pancreas alone, and Pancreas after Kidney)
- Pancreatic Islet Cell Transplant
- Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
- Percutaneous Ultrasonic Ablation of Soft Tissue
- Peripheral Subcutaneous Field Stimulation (PSFS)
- Pharmacogenomic and Pharmacogenetic Testing for Drug Metabolism Status – Non-Cancer Indications
- Platelet-Rich Plasma for the Treatment of NonOrthopedic Indications
- Pneumatic Compression Devices in the Home Setting
- Prolotherapy
- Proteomic Testing for Systemic Therapy in Non-Small Cell Lung Cancer
- Radiofrequency Ablation and Alternative Ablative/Denervation Methods for Chronic Facet Joint Mediated Neck, Back and Sacroiliac Joint Pain
- Radium Ra 223 Dichloride (Xofigo)
- Saliva Hormone Tests
- Serum Tumor Markers in the Management of Malignancies
- Small Bowel Transplant
- Small Bowel/Liver and Multivisceral Transplant
- Spinal Cord and Dorsal Root Ganglion Stimulation
- Steroid – Eluting Sinus Stents and Implants
- Surgical Treatment of Lymphedema
- Tecartus (Brexucabtagene Autoleucel)
- Testing in the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
- Transcranial Magnetic Stimulation
- Treatment for Gastroesophageal Reflux Disease (GERD)
- Treatment of Barrett’s Esophagus
- Tumor Treatment Fields Therapy
- Urinary Incontinence/ Voiding Dysfunction Treatments and Devices
- Vagus Nerve Stimulation (VNS) and Vagal Blocking Therapy
- Vertebral Augmentation
- Vision Therapy/Orthoptic Training
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
- Yescarta (Axicabtagene Ciloleucel)
Click here to view the Blue Cross Blue Shield BCBS Wellmark Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
